The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Hepatitis C Infection in Patients with Primary Hypogammaglobulinemia after Treatment with Contaminated Immune Globulin
Abstract
BACKGROUND: In Scandinavia many patients with primary hypogammaglobulinemia contracted non-A, non-B hepatitis after intravenous treatment with an immune globulin product that was later found to contain a non-A, non-B hepatitis virus. METHODS: We studied the prevalence and clinical course of hepatitis C virus (HCV) infection in a group of 55 Norwegian patients with primary hypogammaglobulinemia and investigated its association with the use of contaminated immune globulin. We used the polymerase chain reaction to detect HCV RNA and performed HCV genotyping. We also analyzed the responses to treatment with interferon. RESULTS: Of 20 patients who received the contaminated immune globulin, 17 were seropositive for HCV RNA: In addition, 1 of 35 patients not exposed to the contaminated immune globulin was HCV RNA--positive. HCV genotype V was found in all 12 patients for whom genotyping was performed, but 8 patients also had genotype II or III, or both. All HCV RNA--positive patients had abnormal results on biochemical liver tests. All liver-biopsy specimens (from 15 patients) were abnormal, with portal inflammation, bile-duct damage, and focal necrosis. In six patients there was cirrhosis. Two patients died of liver failure. In 4 of the 10 patients treated with interferon there were complete, though transient, biochemical responses, but the follow-up biopsy specimens showed evidence of histologic progression. The poorest responses to interferon were among the patients with multiple HCV genotypes. All but one patient remained positive for HCV RNA: CONCLUSIONS: In patients with primary hypogammaglobulinemia there was a high rate of HCV infection after treatment with contaminated immune globulin. In these immunocompromised patients HCV infection has a severe and rapidly progressive course, and responses to interferon are poor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Avoiding false positives with PCR
Kwok, S., & Higuchi, R. (1989) · Nature · doi:10.1038/339237a0 · Cited by 3,441
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
Dusheiko, G., Schmilovitz-Weiss, H., Brown, D., McOmish, F., Yap, P.-L., Sherlock, S., McIntyre, N., & Simmonds, P. (1994) · Hepatology · doi:10.1002/hep.1840190104 · Cited by 561
Okamoto, H., Tokita, H., Sakamoto, M., Horikita, M., Kojima, M., Iizuka, H., & Mishiro, S. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-11-2385 · Cited by 383
Interferon for non-A, non-B chronic hepatitis
Tine', F., Magrin, S., Craxi', A., & Pagliaro, L. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90814-r · Cited by 286
Abnormalities of Immunoregulatory T Cells in Disorders of Immune Function
Reinherz, E. L., Rubinstein, A., Geha, R. S., Strelkauskas, A. J., Rosen, F. S., & Schlossman, S. F. (1979) · New England Journal of Medicine · doi:10.1056/nejm197911083011902 · Cited by 213
Björkander, J., Cunningham‐Rundles, C., Lundin, P., Olsson, R., Söderström, R., & Hanson, L. Å. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90016-2 · Cited by 155
Natural history of AIDS related sclerosing cholangitis: a study of 20 cases.
Forbes, A., Blanshard, C., & Gazzard, B. (1993) · Gut · doi:10.1136/gut.34.1.116 · Cited by 126
NON-A, NON-B HEPATITIS FROM INTRAVENOUS IMMUNOGLOBULIN
Lane, R. S. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90496-8 · Cited by 111
Cited by
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
The Natural History of Hepatitis C Virus (HCV) Infection
Chen, S. L., & Morgan, T. R. (2006) · International Journal of Medical Sciences · doi:10.7150/ijms.3.47 · Cited by 860
Analysis of a Successful Immune Response against Hepatitis C Virus
Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M., Parham, P., & Walker, C. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80044-8 · Cited by 814
Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort Study
Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hürter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W., et al. (1998) · Hepatology · doi:10.1002/hep.510280632 · Cited by 636
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
Rehermann, B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39133 · Cited by 531
Metadata
- Authors
- Bjoro, K., Froland, S. S., Yun, Z., Samdal, H. H., & Haaland, T.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1994-12-15
- Volume
- 331
- Issue
- 24
- Pages
- 1607-1611
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338481731
- Cited by
- 370
- References
- 17
- FWCI
- 24.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatitis C Infection in Patients with Primary Hypogammaglobulinemia after Treatment with Contaminated Immune Globulin. https://app.cochat.ai/papers/10.1056/nejm199412153312402
- The paper
- Bjoro, K., Froland, S. S., Yun, Z., Samdal, H. H., & Haaland, T. (1994). Hepatitis C Infection in Patients with Primary Hypogammaglobulinemia after Treatment with Contaminated Immune Globulin. New England Journal of Medicine. https://doi.org/10.1056/nejm199412153312402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.